Nina Cauchon

Title: Nina Cauchon: Innovator in Pharmaceutical Development

Introduction

Nina Cauchon is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-angiogenic drugs. With a total of 2 patents, her work has the potential to impact medical treatments significantly.

Latest Patents

Nina's latest patents include a process for making a solid-state form of AMG 706, an anti-angiogenic drug. This invention provides AMG 706 in an amorphous form, along with a drug substance where AMG 706 is present in a detectable amount. Additionally, her patent includes an AMG 706-crystallization inhibitor composite, which comprises particles of amorphous AMG 706 or a drug substance in association with one or more crystallization inhibitors, such as polymers. Furthermore, she has developed methods and compositions for making and using polymorphs of cinacalcet hydrochloride.

Career Highlights

Nina Cauchon works at Amgen Inc., a leading biotechnology company. Her innovative approaches in drug formulation and development have positioned her as a key player in the pharmaceutical industry.

Collaborations

Nina has collaborated with notable coworkers, including Belle Bei Liu and Pengzu Zhou. Their teamwork has contributed to the advancement of pharmaceutical technologies and drug development.

Conclusion

Nina Cauchon's contributions to pharmaceutical innovations demonstrate her expertise and commitment to improving medical treatments. Her patents reflect her dedication to advancing drug formulation techniques, which can lead to better therapeutic options for patients.